Amgen AMGN
NASDAQ AMGN
$403.04 -4.23 (-1.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amgen (AMGN) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Amgen (AMGN) posted Depreciation & Amortization (CF) of $1.11 billion for Q2 2026, down 17.1% from $1.34 billion a year earlier and down 0.4% from the prior quarter.

Analysis

Amgen (AMGN) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Amgen was $4.67 billion, down 15.5% year-over-year; for FY2025, it came in at $5.17 billion, down 7.6% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 7.5% (FY2020 to FY2025).
  • In prior years, Amgen's Depreciation & Amortization (CF) was $5.59 billion in FY2024 (+37.4%), $4.07 billion in FY2023 (+19.1%), $3.42 billion in FY2022 (+0.6%) and $3.4 billion in FY2021 (-5.6%).
  • The Q2 2026 figure stands as the lowest quarterly Depreciation & Amortization (CF) since Q3 2023.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last six quarters, with an average decline of 1.2% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q2 2024, with growth of 56.3%; the weakest was Q1 2026, with a decline of 19.5%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $1.12 billion (Q1 2026), $1.13 billion (Q4 2025) and $1.31 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 1.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.93 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.62 Bn
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn 56.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.11 Bn
Mar 31, 2026 1.12 Bn
Dec 31, 2025 1.13 Bn
Sep 30, 2025 1.31 Bn
Jun 30, 2025 1.34 Bn
Mar 31, 2025 1.39 Bn
Dec 31, 2024 1.40 Bn
Sep 30, 2024 1.40 Bn
Jun 30, 2024 1.40 Bn
Mar 31, 2024 1.40 Bn
Dec 31, 2023 1.38 Bn
Sep 30, 2023 895.00 Mn
Jun 30, 2023 896.00 Mn
Mar 31, 2023 900.00 Mn
Dec 31, 2022 911.00 Mn
Sep 30, 2022 837.00 Mn
Jun 30, 2022 828.00 Mn
Mar 31, 2022 841.00 Mn
Dec 31, 2021 852.00 Mn
Sep 30, 2021 850.00 Mn
API Access

Amgen Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AMGN&period=max&api_key=YOUR_API_KEY